PTH Holdings

55 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.

Top 25 Holdings

#HoldingWeightShares (as reported)Value (as reported)
1Iovance Biotherapeutics Inc4.55%988,306$12.8M
2Revolution Medicines Inc3.90%54,476$10.9M
310X Genomics Inc3.85%141,900$10.8M
4Natera Inc3.80%26,958$10.7M
5Guardant Health Inc3.80%63,337$10.7M
6Tenet Healthcare Corp3.74%40,364$10.5M
7Roivant Sciences Ltd3.70%298,702$10.4M
8Insmed Inc3.33%92,025$9.4M
9Twist Bioscience Corp3.17%57,108$8.9M
10Medpace Holdings Inc2.81%13,034$7.9M
11Illumina Inc2.51%26,325$7.0M
12Hinge Health Inc2.46%70,605$6.9M
13Exelixis Inc2.42%116,340$6.8M
14Protagonist Therapeutics Inc2.37%47,127$6.6M
15Halozyme Therapeutics Inc2.32%58,736$6.5M
16Travere Therapeutics Inc2.21%116,089$6.2M
17Oscar Health Inc2.21%188,343$6.2M
18Relay Therapeutics Inc2.20%344,275$6.2M
19Charles River Laboratories International Inc2.15%20,138$6.0M
20CareDx Inc2.05%91,184$5.7M
21PACS Group Inc2.04%132,823$5.7M
22Axogen Inc2.03%158,387$5.7M
23MBX Biosciences Inc1.93%99,154$5.4M
24Dianthus Therapeutics Inc1.88%62,158$5.3M
25Kymera Therapeutics Inc1.77%45,849$5.0M

Sector Weights

  • Healthcare: 100.00%

Country Weights

  • United States: 95.12%
  • United Kingdom: 3.70%
  • Netherlands: 1.08%
  • Other: 0.10%

Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.